Entera Bio Ltd. Ordinary Shares ENTX
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-12T02:57:36.744Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T23:34:44.319406751Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T02:57:36.399593+00:00
Entera Bio Ltd. Ordinary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | 4.16 | 568.0% | 25.5% | |||
| 50Δ | 4.48 | 542.8% | 21.9% | |||
| 55Δ | 4.81 | 517.7% | 18.3% | |||
| 60Δ | 3.14 | 119.4% | 8.0% | |||
| 65Δ | 3.01 | 109.1% | 4.7% | |||
| 70Δ | ||||||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.16
- IV
- 568.0%
- B/E move
- 25.5%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.48
- IV
- 542.8%
- B/E move
- 21.9%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.81
- IV
- 517.7%
- B/E move
- 18.3%
60Δ
- Pseudo strike
- 3.14
- IV
- 119.4%
- B/E move
- 8.0%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 3.01
- IV
- 109.1%
- B/E move
- 4.7%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 227.15% | |
| 220.59% |
Biotechnology
ERAS
Erasca Inc. is a pioneering biopharmaceutical firm specializing in the development of targeted therapies for genetically defined cancers, aiming to meet significant unmet needs in…
More →EVMN
Description unavailable
More →EWTX
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The company is headquartered in Boulder, Colorado.
More →EXEL
Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The…
More →EYPT
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United…
More →FATE
Description unavailable
More →